AllianceBernstein’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Hold
35,600
﹤0.01% 2789
2025
Q4
$371K Hold
35,600
﹤0.01% 2807
2025
Q3
$320K Sell
35,600
-1,500
-4% -$13.2K ﹤0.01% 2916
2025
Q2
$482K Hold
37,100
﹤0.01% 2659
2025
Q1
$937K Hold
37,100
﹤0.01% 2281
2024
Q4
$1.28M Hold
37,100
﹤0.01% 2197
2024
Q3
$1.83M Hold
37,100
﹤0.01% 2007
2024
Q2
$2.23M Buy
37,100
+6,760
+22% +$386K ﹤0.01% 1885
2024
Q1
$1.56M Buy
30,340
+11,000
+57% +$540K ﹤0.01% 2047
2023
Q4
$780K Hold
19,340
﹤0.01% 2393
2023
Q3
$539K Hold
19,340
﹤0.01% 2537
2023
Q2
$557K Buy
+19,340
New +$430K ﹤0.01% 2578
2022
Q3
Sell
-17,194
Closed -$242K 3300
2022
Q2
$242K Buy
+17,194
New +$227K ﹤0.01% 2953

Other funds holding RXST

AllianceBernstein's RXST Position: Q1 2026 in Review

AllianceBernstein held its RxSight (RXST) position steady in Q1 2026 at 35,600 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

AllianceBernstein first reported a position in RXST in Q2 2022 and has held it in 13 quarters since. The position peaked at $2.23M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • AllianceBernstein held 35,600 shares of RxSight worth $371K as of Q1 2026.
  • AllianceBernstein left its RxSight share count unchanged in Q1 2026.
  • RxSight made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2789 holding.
  • AllianceBernstein first reported a position in RxSight in Q2 2022 and has held it in 13 quarters since.
  • AllianceBernstein's RxSight position peaked at $2.23M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.